Cargando…
Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
Objective. Patients with gastroenteropancreatic neuroendocrine carcinoma (NEC) have a poor prognosis. Platinum-based combination chemotherapy is commonly used as first-line treatment; however, the role of salvage chemotherapy remains unknown. This study aimed to analyze the efficacy and safety of am...
Autores principales: | Ando, Takayuki, Hosokawa, Ayumu, Yoshita, Hiroki, Ueda, Akira, Kajiura, Shinya, Mihara, Hiroshi, Nanjo, Sohachi, Fujinami, Haruka, Nishikawa, Jun, Ogawa, Kohei, Nakajima, Takahiko, Imura, Johji, Sugiyama, Toshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493294/ https://www.ncbi.nlm.nih.gov/pubmed/26199623 http://dx.doi.org/10.1155/2015/425876 |
Ejemplares similares
-
Neuroendocrine Carcinoma of the Stomach: A Response to Combination Chemotherapy Consisting of Ramucirumab Plus Paclitaxel
por: Matsubara, Yuki, et al.
Publicado: (2017) -
Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori‐infected human gastric epithelium
por: Mihara, Hiroshi, et al.
Publicado: (2016) -
Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea
por: Sakumura, Miho, et al.
Publicado: (2020) -
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study
por: Kajiura, Shinya, et al.
Publicado: (2015) -
Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial
por: Ueda, Akira, et al.
Publicado: (2013)